The British government believes weight-loss drugs could play a role in its push to reduce the number of long-term unemployed ...

A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half. What doesn’t it ...

Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.

The stock of Eli Lilly and Company LLY has declined 1.7% already this week, losing almost $14 billion of its market value.

The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

Academic notes while Ozempic might prevent overdoses, weight loss drug may not actually reduce or end substance use ...

The drugmaker's financial results are also impressive, spearheaded by tirzepatide, a therapy for diabetes and obesity that is ...

First patient dosed with ISP-001 shows reduced urinary GAG level, functional improvements surpassing enzyme replacement ...

We came across a bullish thesis on Altimmune, Inc. (ALT) on WallStreetBets subreddit page by Old-Pomegranate3634. In this ...

It is primary aim is to analyse how tirzepatide, sold by Eli Lilly under the brand name Mounjaro, reduces obesity and other ...

In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb ...

Lilly has been solidly investing in research and development (R&D) throughout 2024. In April, the company announced the ...